Startup Ansa Bio lands $68M to go long with enzymes approach to DNA synthesis
The DNA currently used in genetic medicines research is synthesized by chemical methods. Ansa Biotechnologies employs faster and less expensive enzymes-based technology, and the startup has raised capital to scale up operations as it prepares to launch its service.
Source: medcitynews.com